|
1QB2
CRYSTAL STRUCTURE OF THE CONSERVED SUBDOMAIN OF HUMAN PROTEIN SRP54M AT 2.1A RESOLUTION: EVIDENCE FOR THE MECHANISM OF SIGNAL PEPTIDE BINDING
Deposited 1999-04-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
326–434(109 aa)
Fragment:SRP54
Chain B
326–434(109 aa)
Fragment:SRP54
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;30% PEG 2K, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.10 Å
R-free 0.318
|
|
5L3Q
Structure of the GTPase heterodimer of human SRP54 and SRalpha
Deposited 2016-05-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–436(436 aa)
|
Not recorded
|
SO4 SULFATE ION × 5
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2
MG MAGNESIUM ION × 2
GOL GLYCEROL × 2
AMP ADENOSINE MONOPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;100 mM Tris pH 8.0, 400 mM lithium sulfate, 10 % (w/v) PEG 8000
|
Resolution 3.20 Å
R-free 0.191
|
|
5L3Q
Structure of the GTPase heterodimer of human SRP54 and SRalpha
Deposited 2016-05-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–436(436 aa)
|
Not recorded
|
SO4 SULFATE ION × 4
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2
MG MAGNESIUM ION × 2
GOL GLYCEROL × 2
AMP ADENOSINE MONOPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;100 mM Tris pH 8.0, 400 mM lithium sulfate, 10 % (w/v) PEG 8000
|
Resolution 3.20 Å
R-free 0.191
|
|
6Y2Z
NG domain of human SRP54
Deposited 2020-02-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–296(296 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291.15 K;na2hpo4 0.8 M
K2HPO4 0.8 M
HEPES 0.1 M (pH 7.5)
|
Resolution 2.15 Å
R-free 0.246
|
|
6Y2Z
NG domain of human SRP54
Deposited 2020-02-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–296(296 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291.15 K;na2hpo4 0.8 M
K2HPO4 0.8 M
HEPES 0.1 M (pH 7.5)
|
Resolution 2.15 Å
R-free 0.246
|
|
6Y30
NG domain of human SRP54 T115A mutant
Deposited 2020-02-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–296(296 aa)
|
Mutation:T115A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291.15 K;1M Potassium Citrate
|
Resolution 2.65 Å
R-free 0.309
|
|
6Y30
NG domain of human SRP54 T115A mutant
Deposited 2020-02-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–296(296 aa)
|
Mutation:T115A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291.15 K;1M Potassium Citrate
|
Resolution 2.65 Å
R-free 0.309
|
|
6Y31
NG domain of human SRP54 T117 deletion mutant
Deposited 2020-02-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–296(296 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291.15 K;0.8 M Na2HPO4 , 0.8 M K2HPO4
HEPES 0.1 M (pH 7.5)
|
Resolution 4.00 Å
R-free 0.331
|
|
6Y31
NG domain of human SRP54 T117 deletion mutant
Deposited 2020-02-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–296(296 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291.15 K;0.8 M Na2HPO4 , 0.8 M K2HPO4
HEPES 0.1 M (pH 7.5)
|
Resolution 4.00 Å
R-free 0.331
|
|
6Y31
NG domain of human SRP54 T117 deletion mutant
Deposited 2020-02-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–296(296 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291.15 K;0.8 M Na2HPO4 , 0.8 M K2HPO4
HEPES 0.1 M (pH 7.5)
|
Resolution 4.00 Å
R-free 0.331
|
|
6Y31
NG domain of human SRP54 T117 deletion mutant
Deposited 2020-02-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–296(296 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291.15 K;0.8 M Na2HPO4 , 0.8 M K2HPO4
HEPES 0.1 M (pH 7.5)
|
Resolution 4.00 Å
R-free 0.331
|
|
6Y32
Structure of the GTPase heterodimer of human SRP54 and SRalpha
Deposited 2020-02-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–296(296 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2
MG MAGNESIUM ION × 2
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291.15 K;0.4 M lithium sulfate, 13% (w/v) PEG 3350, 0.1 M Tris (pH 8.0)
|
Resolution 2.60 Å
R-free 0.184
|
|
6Y32
Structure of the GTPase heterodimer of human SRP54 and SRalpha
Deposited 2020-02-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–296(296 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2
MG MAGNESIUM ION × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291.15 K;0.4 M lithium sulfate, 13% (w/v) PEG 3350, 0.1 M Tris (pH 8.0)
|
Resolution 2.60 Å
R-free 0.184
|
|
6Y32
Structure of the GTPase heterodimer of human SRP54 and SRalpha
Deposited 2020-02-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
1–296(296 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2
MG MAGNESIUM ION × 2
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291.15 K;0.4 M lithium sulfate, 13% (w/v) PEG 3350, 0.1 M Tris (pH 8.0)
|
Resolution 2.60 Å
R-free 0.184
|
|
6Y32
Structure of the GTPase heterodimer of human SRP54 and SRalpha
Deposited 2020-02-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain G
1–296(296 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2
MG MAGNESIUM ION × 2
SO4 SULFATE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291.15 K;0.4 M lithium sulfate, 13% (w/v) PEG 3350, 0.1 M Tris (pH 8.0)
|
Resolution 2.60 Å
R-free 0.184
|
|
7NFX
Mammalian ribosome nascent chain complex with SRP and SRP receptor in early state A
Deposited 2021-02-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Heteromer;Protein × 51
PDB declaration: 55-meric
|
Chain x
1–504(504 aa)
|
Not recorded
|
ZN ZINC ION × 5
MG MAGNESIUM ION × 2
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE
|
Resolution 3.20 Å
|
|
7QWQ
Ternary complex of ribosome nascent chain with SRP and NAC
Deposited 2022-01-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Heteromer;Protein × 48
PDB declaration: 52-meric
|
Chain x
1–504(504 aa)
|
Not recorded
|
MG MAGNESIUM ION × 97
ZN ZINC ION × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE
|
Resolution 2.83 Å
|